Parenteral trimethoprim-sulfamethoxazole and carbenicillin as empiric therapy for neutropenic patients with cancer

Hayden G. Braine, Robert K. Stuart, Rein Saral, Paul S. Lietman

Research output: Contribution to journalArticlepeer-review

Abstract

A combination of parenteral trimethoprim-sulfamethoxazole and carbenicillin (TMPSMZ- C) was compared with a gentamicin and carbenicillin combination (G-C) as empiric therapy for the febrile neutropenic patient with cancer in a prospective doubleblind trial. Target plasma levels of TMP were achieved easily. When all trials were considered, TMP-SMZ-C was more effective (P ⩽ 0.045) than G-C. When only proven infections were considered, the two regimens were equally effective. Adverse effects of both regimens were similar. Experience with infections due to individual organisms, particularly Pseudomonas aeruginosa and Staphylococcus aureus, was limited. General recommendations for use of TMP-SMZ-C in this patient population cannot be made until more comprehensive studies are done.

Original languageEnglish (US)
Pages (from-to)586-592
Number of pages7
JournalReviews of infectious diseases
Volume4
Issue number2
DOIs
StatePublished - Mar 1982

ASJC Scopus subject areas

  • Microbiology (medical)

Fingerprint Dive into the research topics of 'Parenteral trimethoprim-sulfamethoxazole and carbenicillin as empiric therapy for neutropenic patients with cancer'. Together they form a unique fingerprint.

Cite this